期刊文献+

TGF-β1基因多态性与高级别宫颈上皮内瘤变易感性的关系

Relationship of transforming growth factor-β1 polymorphisms and susceptibility of high grade cervical intraepithelial neoplasia
原文传递
导出
摘要 目的研究转化生长因子β1(TGF-β1)基因多态性与高级别宫颈上皮内瘤变(CINⅡ-Ⅲ)遗传易感性的关系。方法选择191例CINⅡ-Ⅲ患者为病例组,207例年龄相匹配的正常者为对照组,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术检测TGF-β1基因C509T和T869C多态性在两组中的频率和分布,比较不同基因型携带者患CINⅡ-Ⅲ的危险性。结果与携带T869CTT基因型相比,携带T869CTC/CC基因型者罹患CINⅡ-Ⅲ的风险升高1.582倍(OR=1.582,95%CI=1.026-2.438,P<0.05)。产次0-1次和不吸烟的女性携带T869CTC/CC基因型较携带TT基因型者罹患CINⅡ-Ⅲ的风险升高更为显著(P<0.05)。结论 TGF-β1T869C多态性可能与人群CINⅡ-Ⅲ的遗传易感性相关。 Objective To evaluate the association of transforming growth factor-β1(TGF-β1) polymorphisms and risk for high grade cervical intraepithelial neoplasia(CINⅡ-Ⅲ).Methods With polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP)method,TGF-β1 C509Tand TGF-β1 T869Cpolymorphisms were detected and the risk factors for CINⅡ-Ⅲ were compared in 191women with CINⅡ-Ⅲ(group A)and 207controls(group C).Results The risk for CINⅡ-Ⅲin the cases carrying T869CTC/CC genotypes was 1.582times more than those carrying TT genotype(OR=1.582,95%CI=1.026-2.438,P〈0.05).The risk for CINⅡ-Ⅲ in women carrying TC/CC genotypes was even more pronounced with parity ≤1and nonsmoker.Conclusion The TGF-β1 T869C polymorphism may contribute to the susceptibility of high grade cervical intraepithelial neoplasia.
出处 《江苏医药》 CAS 北大核心 2013年第15期1768-1771,共4页 Jiangsu Medical Journal
基金 江苏省自然科学基金(BK2012878)
关键词 转化生长因子Β1 高级别宫颈上皮内瘤变 单核苷酸多态性 Transforming growth factor-β1 High grade cervical intraepithelial neoplasia Polymorphism
  • 相关文献

参考文献15

  • 1Thomas DA, Massague J. TGF-beta directly targets cytotoxicT cell functions during tumor evasion of immune surveillance[J]. Cancer Cell,2005,8(5):369-380.
  • 2Serraino D, Carrieri P, Pradier C,et al. Risk of invasivecervical cancer among women with, or at risk for, HIVinfection[J]. Int J Cancer, 1999,82(3) :334-337.
  • 3Stanley MA. Immunobiology of papillomavirus infections[J].J Reprod Immunol,2001,52(1-2) :45-59.
  • 4Nakagawa M,Stites DP,Palefsky JM,et al. CD4~positive andCD8-positive cytotoxic T lymphocytes contribute to humanpapillomavirus type 16 E6 and E7 responses[J]. Clin DiagnLab Immunoi, 1999,6(4) :494-498.
  • 5Youde SJ, Dunbar PR, Evans EM, et al. Use of fluorogenichistocompatibility leukocyte antigen-A * 0201/HPV 16 E7peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirusantigens[J]. Cancer Res,2000,60(2) :365-371.
  • 6Elliott RL, Blobe GC. Role of transforming growth factorbeta in human cancer [J], J Clin Oncol, 2005,23 (9) : 2078-2093.
  • 7Spellberg B, Edwards JE Jr. Type 1/Type 2 immunity ininfectious diseases[J]. Clin Infect Dis,2001,32(1) : 76-102.
  • 8Blobe GC.Schiemann WP,Lodish HF. Role of transforminggrowth factor beta in human disease [J]. N Engl J Med,2000,342(18):1350-1358.
  • 9Lin CM,Wang FH,Lee PK. Activated human CD4+ T cellsinduced by dendritic cell stimulation are most sensitive totransforming growth factor-beta: implications for dendriticcell immunization against cancer[J]. Clin Immunol,2002,102(1):96-105.
  • 10Gorelik L, Constant S, Fla veil RA. Mechanism of transfor-ming growth factor beta-induced inhibition of T helper type 1differentiation[J]. J Exp Med.2002,195(11) *1499-1505.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部